abstract |
THE INVENTION CONCERNS THE PHARMACEUTICAL INDUSTRY. IT IS A NEW DERIVATIVE OF VITAMIN D, KNOWING 26,26,26,27,27,27-HEXAFLUORO-1A, 25-DIHYDROXYCHOLECALCIFEROL, IN ADDITION TO A PROCESS FOR PREPARING IT. THIS COMPOUNDS HAS A VITAMINOID D ACTIVITY SENSITIVELY HIGHER THAN THAT OF 1A, 25-DIHYDROXYCHOLECALCIFEROL. THIS COMPOUND IS A PREFERRED APPLICATION AS A REPLACEMENT OF VITAMIN D FOR THE TREATMENT OR PROPHYLAXIS OF CONDITIONS IN WHICH CALCIUM AND PHOSPHORUS METABOLISM DISORDERS OCCUR. |